Next 10 |
2024-04-19 17:10:25 ET More on NLS Pharmaceutics Seeking Alpha’s Quant Rating on NLS Pharmaceutics Historical earnings data for NLS Pharmaceutics Financial information for NLS Pharmaceutics Read the full article on Seeking Alpha For further det...
ZÜRICH, SWITZERLAND / ACCESSWIRE / March 22, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervo...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...
ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 28.7% to $0.0887 on volume of 95,670,653 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 21.5% to $0.0243 on volume of 91,833,714 shares Oblong Inc. (OBLG) rose 45.2% to $0.19605 on volume of 60,847,1...
The exclusive License Agreement grants NLS Pharmaceutics global rights to next-generation non-sulfonamide orexin-1 / orexin-2 receptor agonists, tailored to target multiple pathways in neuropharmacological therapies. Medications activating dual OX1R/OX2R target a broader range of mechanisms ...
ZURICH, SWITZERLAND / ACCESSWIRE / March 14, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...
2024-03-11 07:31:15 ET More on NLS Pharmaceutics Seeking Alpha’s Quant Rating on NLS Pharmaceutics Historical earnings data for NLS Pharmaceutics Financial information for NLS Pharmaceutics Read the full article on Seeking Alpha For further det...
ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...
ZÜRICH, SWITZERLAND / ACCESSWIRE / February 23, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central ne...
News, Short Squeeze, Breakout and More Instantly...
NLS Pharmaceutics Ltd. Company Name:
NLSP Stock Symbol:
NASDAQ Market:
ZÜRICH, SWITZERLAND / ACCESSWIRE / March 22, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervo...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...
ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...